NPPA extends price regulation on oxygen concentrators

The Authority further decided that the matter be forwarded to SCAMHP for its recommendations

NPPA Price of drugs

Last Updated on November 27, 2021 by The Health Master

The National Pharmaceutical Pricing Authority (NPPA) has decided to extend the notification related to price regulation of oxygen concentrators based on the Trade Margin Rationalisation (TMR) approach applicable for six more months, till May 30, 2022.

Besides, the period to report stock details of four medical devices—bare metal stents, drug eluting stents, orthopaedic knee implants, and oxygen concentrators has been relaxed from a monthly to a quarterly basis.

The Authority, in its meeting held on November 15, noted that the notification issued in June, 2021, related to price regulation of oxygen concentrators based on the TMR approach, is applicable to November 30, 2021.

The recommendations of the Standing Committee on Affordable Medicines and Health Products (SCAMHP) in its fourth and fifth meetings, held on May 25 and 30, this year, were also taken into account by the authorities before deciding on the extension of the price regulation period.

“The authorities deliberated upon the matter in detail and were of the opinion that, as the C-19 pandemic is still a risk to public health; availability of oxygen concentrators at affordable prices must be ensured, according to the minutes to the meeting.

Hence, it was decided that the notification be extended, before it expires, for another six months up to May 30, 2022. The Authority further decided that the matter be forwarded to SCAMHP for its recommendations.

According to the notification issued by the Authority in June, 2021, the Government has put a cap on the trade margin of oxygen concentrators at the first point of sale of the product, at 70 percent.

In the same meeting, the Authority discussed the topic related to changing the reporting of stock related submissions quarterly instead of monthly for certain capped medical devices.

The Authority deliberated upon the matter in detail and decided that the submission of information relating to stock details of medical devices, namely, bare metal stents, drug eluding stents, orthopaedic knee implants and oxygen concentrators, may be reported on quarterly basis instead of monthly.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

NPPA will not intervene in complaints involving commercial interests

Pharmexcil urges govt to lift restriction on export of Remdesivir &…

Clinical trials of Nasal Spray for COVID-19 prevention started

Govt appoints Deepak Gaikwad as State Licensing Authority FDA Karnataka

Govt: These agencies can conduct studies on Pharma & Medical Devices

Cost of Raw Materials for Drugs increased from 11% to 51%

World’s biggest Vegetarian Capsules plant to come in India

Govt endorses these suggestions to amend D&C Act and DPCO

2 lakh Pharmacies in India by next year: Biddano

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner